DIA
Drug Information Association Logo

Office of Prescription Drug Promotion (OPDP) Enforcement Overview From 1997 to 2013

Time

Wed, Jun 18 7:15AM
W 38

Title

Office of Prescription Drug Promotion (OPDP) Enforcement Overview From 1997 to 2013

Abstract Summary

Warning and untitled letters sent (1997-2013) were analyzed. For warning letters, deviations from 21 CFR were identified and placed into 4 categories—Prescription Drug Advertising, Labeling, New Drug Promotion, and Investigational Drug Promotion—and within each, the numbers of citations were ranked.

Poster Presenter

Cyril Alexandre Carrere
MSc,
Managing Editor, Regulatory Intelligence, Analytics,
Thomson Reuters (Scientific) Ltd.
France